LCNB
Q3 2026 EPS Estimate
$0.43
Jul 28, 2026 · Reports before open
Revenue Estimate
$24M
FY2026E EPS$1.68
FY2027E EPS$1.81

Analyst Sentiment

Wall St. Consensus
Hold
3 analysts·Low coverage
58
Score
1 Buy (33%)2 Hold (67%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
133%
Hold
267%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$19.00
+6.2%
Consensus
$19.00
+6.2%
Bull
$19.00
+6.2%
12-Month Target Range3 analysts
$19.00$19.00$19.00
Current $17.89Consensus
Current Price
$17.89
Upside to Consensus
$1.11

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.41%
EPS+8.06%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$97M$100M
Low$97M$100M
High$97M$100M
EBITDA Avg$25M$26M
Low$25M$26M
High$25M$26M
EBIT Avg$23M$24M
Low$23M$24M
High$23M$24M
Net Income Avg$24M$25M
Low$24M$25M
High$24M$26M
EPS Avg$1.68$1.81
Low$1.67$1.81
High$1.68$1.81
Analysts (Rev / EPS)1 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$25M$25M$24M$25M$25M$26M
Low$24M$25M$24M$25M$25M$26M
High$25M$25M$24M$25M$25M$26M
EBITDA Avg$6M$6M$6M$6M$7M$7M
Low$6M$6M$6M$6M$7M$7M
High$6M$6M$6M$6M$7M$7M
EBIT Avg$6M$6M$6M$6M$6M$6M
Low$6M$6M$6M$6M$6M$6M
High$6M$6M$6M$6M$6M$6M
Net Income Avg$6M$7M$6M$6M$7M$7M
Low$6M$7M$6M$6M$7M$7M
High$7M$7M$6M$6M$7M$7M
EPS Avg$0.46$0.47$0.43$0.44$0.47$0.47
Low$0.46$0.46$0.43$0.44$0.46$0.46
High$0.46$0.47$0.43$0.44$0.47$0.47
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Nov 30, 2022Janney Montgomery
Janney Montgomery Scott Initiates Coverage On LCNB with Neutral Rating, Announces Price Target of $19
Target:$19.00
+3.1%from $18.42
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.